checkAd

    EQS-News  117  0 Kommentare GEA’s factory in Elsdorf sets new standards in pharmaceutical production

    Für Sie zusammengefasst
    • GEA's new factory in Elsdorf sets new standards in pharmaceutical production
    • Construction work meets highest sustainability standards
    • GEA invests EUR 80 million to expand in pharmaceutical market

    EQS-News: GEA Group Aktiengesellschaft / Key word(s): Miscellaneous
    GEA’s factory in Elsdorf sets new standards in pharmaceutical production

    22.03.2024 / 12:00 CET/CEST
    The issuer is solely responsible for the content of this announcement.


    GEA’s factory in Elsdorf sets new standards in pharmaceutical production

    Anzeige 
    Handeln Sie Ihre Einschätzung zu GEA Group Aktiengesellschaft!
    Long
    33,84€
    Basispreis
    0,39
    Ask
    × 9,60
    Hebel
    Short
    41,18€
    Basispreis
    0,40
    Ask
    × 9,36
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    • Groundbreaking ceremony for GEA’s second “Factory of the Future” covering an area of over 40,000 m2 in Elsdorf, Germany
    • Construction work meets the highest sustainability standards in line with the company’s manufacturing strategy
    • All 250 employees from the current location in Hürth to relocate to the new plant
    • GEA is investing EUR 80 million to further its growth in the pharmaceutical freeze-drying market
    • New factory scheduled to open in the second half of 2025
       

    Düsseldorf, March 22, 2024 – Construction of GEA’s new pharmaceutical technology center in Elsdorf, Germany, begins today – setting new industry benchmarks. The machinery and plant manufacturer is investing EUR 80 million in the new freeze-drying systems facility. These systems are used in the production of numerous injectable pharmaceuticals, including vaccines. The new facility is scheduled to open in the second half of 2025.

    With people increasingly aware of the major role immunization plays in preventing disease, the market for vaccines is growing rapidly worldwide. In order to meet this rising demand, GEA opted to build a new plant, as capacities at the existing facility in Hürth were nearing their limits. All 250 employees are to relocate to the new plant.

    “This investment will open the door to our onward growth as well as improved innovation opportunities in the pharmaceutical sector, which is strategically significant for us. The new plant will enable us to align even more closely with our customers’ needs and expand our leading market position,” says GEA CEO Stefan Klebert.

    Construction starts on GEA’s second “Factory of the Future” covering over 40,000

    Following the opening of the first factory in Poland in 2022, the second plant of its kind – covering an area of over 40,000 m² – is now being built in Germany.

    Seite 1 von 4


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-News GEA’s factory in Elsdorf sets new standards in pharmaceutical production EQS-News: GEA Group Aktiengesellschaft / Key word(s): Miscellaneous GEA’s factory in Elsdorf sets new standards in pharmaceutical production 22.03.2024 / 12:00 CET/CEST The issuer is solely responsible for the content of this announcement. GEA’s …